Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CSPI Wants to Sue Bayer for Misleading Ads - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

CSPI Wants to Sue Bayer for Misleading Ads

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

The Center for Science in the Public Interest (CSPI), Washington, D.C., has notified Bayer Healthcare, Morristown, NJ, that it will sue the company if it continues to claim that the selenium in its One A Day vitamins may reduce men’s risk of prostate cancer, the organization announced June 18. Advertisements and labels for One A Day Men’s 50+ Advantage and One A Day Men’s Health Formula multivitamins claim that “emerging research” suggests that selenium may reduce the risk of prostate cancer. But leading prostate cancer researchers say there is scant evidence to support such a claim and have joined CSPI in urging FTC to put an immediate stop to the deceptive claims. “Bayer is exploiting men’s fear of prostate cancer just to sell more pills,” said CSPI senior nutritionist David Schardt. “The largest prostate cancer prevention trial has found that selenium is no more effective than a placebo. Bayer is ripping people off when it suggests otherwise in these dishonest ads.”

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics